Reliability of <it>KRAS</it> mutation testing in metastatic colorectal cancer patients across five laboratories

<p>Abstract</p> <p>Background</p> <p>Mutations in the <it>KRAS</it> gene are associated with poor response to epidermal growth factor receptor inhibitors used in the treatment of metastatic colorectal cancer. Factors influencing <it>KRAS</it> tes...

Full description

Bibliographic Details
Main Authors: Feigelson Heather, Goddard Katrina AB, Johnson Monique A, Funk Kellyan C, Rahm Alanna, Kauffman Tia L, Chitale Dhananjay A, Le Marchand Loic, Richards C
Format: Article
Language:English
Published: BMC 2012-04-01
Series:BMC Research Notes
Subjects:
Online Access:http://www.biomedcentral.com/1756-0500/5/196